124 related articles for article (PubMed ID: 7538830)
41. Multiple coronary thrombi with cisplatin.
Karabay KO; Yildiz O; Aytekin V
J Invasive Cardiol; 2014 Feb; 26(2):E18-20. PubMed ID: 24486672
[TBL] [Abstract][Full Text] [Related]
42. Chemotherapy-induced infertility in patients with testicular cancer.
Bradford BR
Oncol Nurs Forum; 2012 Jan; 39(1):27-30. PubMed ID: 22201652
[No Abstract] [Full Text] [Related]
43. New onset psychosis in an adolescent during treatment of testicular germ cell tumor.
Campbell BA; Panicker J
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e125-6. PubMed ID: 21383636
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin.
Stephenson WT; Poirier SM; Rubin L; Einhorn LH
J Clin Oncol; 1995 Sep; 13(9):2278-80. PubMed ID: 7545220
[TBL] [Abstract][Full Text] [Related]
45. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
[TBL] [Abstract][Full Text] [Related]
46. Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors: selection criteria and long-term results.
Lerner SE; Mann BS; Blute ML; Richardson RL; Zincke H
Mayo Clin Proc; 1995 Sep; 70(9):821-8. PubMed ID: 7543967
[TBL] [Abstract][Full Text] [Related]
47. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
[TBL] [Abstract][Full Text] [Related]
48. Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group.
Bamias A; Aravantinos G; Kastriotis I; Alivizatos G; Anastasiou I; Christodoulou C; Gyftaki R; Kalofonos HP; Dimopoulos MA
Urol Oncol; 2011; 29(2):189-93. PubMed ID: 19362863
[TBL] [Abstract][Full Text] [Related]
49. Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide.
Dietrich J; Marienhagen J; Schalke B; Bogdahn U; Schlachetzki F
Ann Pharmacother; 2004 Feb; 38(2):242-6. PubMed ID: 14742759
[TBL] [Abstract][Full Text] [Related]
50. [Arterial thrombosis in a patient after chemotherapy (BEP protocol) for extra-gonadal dysgerminoma].
Schmidt J; Zenut M; De Marquilly F; Maciejewski C; Plagne R; Lavarenne J
Therapie; 1995; 50(5):476-8. PubMed ID: 8571294
[No Abstract] [Full Text] [Related]
51. [Chemotherapy of testicular cancer].
Witjes JA; Debruyne FM
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):557-60. PubMed ID: 10321273
[TBL] [Abstract][Full Text] [Related]
52. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
53. Fatal cerebrovascular accident associated with chemotherapy for testicular cancer.
Gerl A; Clemm C; Schleuning M; Wilmanns W
Eur J Cancer; 1993; 29A(8):1220-1. PubMed ID: 7686022
[No Abstract] [Full Text] [Related]
54. 5-Fluorouracil-induced vasospastic angina.
Ayyildiz O; Karabulut A; Isikdogan A; Cakir O; Dursun M
Ann Saudi Med; 2005; 25(3):263-5. PubMed ID: 16119534
[No Abstract] [Full Text] [Related]
55. Acute tumor lysis syndrome with choriocarcinoma.
Blanke CD; Hemmer MP; Witte RS
South Med J; 2000 Sep; 93(9):916-9. PubMed ID: 11005356
[TBL] [Abstract][Full Text] [Related]
56. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
57. Primary chemotherapy for stage 2 testis cancer.
Abratt RP; McAdam GL; Pontin AR; Barnes RD; Ball HS
S Afr J Surg; 1997 Nov; 35(4):203-5; discussion 205-6. PubMed ID: 9540399
[TBL] [Abstract][Full Text] [Related]
58. Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Lopes LF; Macedo CR; Aguiar Sdos S; Barreto JH; Martins GE; Sonaglio V; Milone M; Lima ER; Almeida MT; Lopes PM; Watanabe FM; D'Andrea ML; Pianovski MA; Melaragno R; Vianna SM; Moreira ME; Bruniera P; de Oliveira CZ
J Clin Oncol; 2016 Feb; 34(6):603-10. PubMed ID: 26729441
[TBL] [Abstract][Full Text] [Related]
59. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
60. Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer.
Eeles R; Tait DM; Peckham MJ
Cancer Treat Rep; 1986 Jul; 70(7):905-7. PubMed ID: 2424594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
